Coumarin derivatives protection against ROS production in cellular models of Aβ toxicities

Free Radical Research

Volumn 41, Issue 10, 2007, Pages 1168-1180

  Kontogiorgis, Christos A ^a,b   Xu, Yanan ^b   Hadjipavlou Litina, Dimitra ^a   Luo, Yuan ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

.9 mutant cells; amyloid peptide; Coumarin; Hydrogen peroxide scavengers; N2a neuroblastoma cells

Indexed keywords

AMYLOID BETA PROTEIN; COUMARIN DERIVATIVE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; UMBELLIFERONE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION; SCAVENGING SYSTEM; TRANSGENICS; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CELL LINE, TUMOR; COUMARINS; FREE RADICALS; HUMANS; HYDROGEN PEROXIDE; MICE; MICE, TRANSGENIC; MODELS, CHEMICAL; MUTATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 34748864811     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701447884     Document Type: Article

References (63)

1. Christen, YM. (2000) Oxidateve stress and Alzheimer disease. Am J Clin Nutr, 71, pp. 621S-629S.
2. Mattson, MP. (2000) Risk factors and mechanisms of Alzheimer's disease pathogenesis: Obviously and obviously not. J Alzheimers Dis, 2, pp. 109-112.
3. Butterfield, DA. (2003) Amyloid beta-peptide [1-42] associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: Mechanisms and consequences. Curr Med Chem, 10, pp. 2651-2659.
4. Selkoe, DJ. (2001) Alzheimer's disease: Genes, proteins ad therapy. Physiol Rev, 81, pp. 741-766.
5. Smith, MA and Perry, G. (2000) Molecular and cellular aspects of oxidative damage in Alzheimer's disease. Free radicals in brain pathophysiology, pp. 313-321. Poli G, Torino
6. Yatin, SM, Varadarajan, S. and Butterfield, DA. (2000) Vitamin E prevents Alzheimer's amyloid veta-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J Alzheimers Dis, 2, pp. 123-131.
7. Dumery, L., Bourdel, F., Soussan, Y., Fialkowsky, A., Viale, S., Nicolas, P. and Reboud-Ravaux, M. (2001) β-Amyloid peptide protein aggregation: Its implication in the physiopathology of Alzheimer's disease. Pathol Boil (Paris), 49, pp. 72-85.
8. Selkoe, DJ. (1989) The deposition of amyloid proteins in the aging mammalian brain: Implications for Alzheimer's disease. Ann Med, 21, pp. 73-76.
9. Bayer, TA, Wirths, O., Majtenyi, K., Jartmann, T., Multhaup, G., Beyreuther, K. and Czech, C. (2001) Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol, 11, pp. 1-11.
10. Hass, C., Schlossmacher, MG, Hung, AY, Vigo-Pelfrey, C., Mellon, A., Ostaszewski, BL, Lieberburg, I., Koo, EH, Schenk, D., Teplow, DB and Selkoe, DJ. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature, 359, pp. 322-325.
11. Christen, Y. and Maixent, JM. (2002) What is Gingko biloba extract EGb 761? An overview-from molecular biology to clinical medicine. Cell Mol Biol, 48, pp. 601-611.
12. Selkoe, DJ. (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem, 271, pp. 18295-18298.
13. Murrell, J., Farlow, M., Ghetti, B. and Benson, M. (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science, 254, pp. 97-99.
14. Guo, Q., Robinson, N. and Mattson, MP. (1998) Secreted β-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NFkB and stabilization of calcium homeostasis. J Biol Chem, 273, pp. 12341-12351.
15. Yatin, SM, Varadarajan, S., Link, CD and Butterfield, DA. (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42). Neur Aging, 20, pp. 325-330.
16. Ka, MH, Choi, EH, Chun, HS and Lee, KG. (2005) Antioxidative activity of volatile extracts isolated from Angelica tenuissimae roots, peppermint leaves, pine needles and sweet flag leaves. J Agric Food Chem, 53, pp. 4124-4129.
17. Molina-Jimenez, MF, Sanchez-Reus, MI, Andres, D., Cascales, M. and Benedi, J. (2004) Neuroprotective effect of fraxetin and myricatin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res, 1009, pp. 9-16.
18. 2 or Cu (II) ions in B14 chinese hamster cells. Cell Biol Intern, pp. 761-768.
19. Hackett, SF, Mincey, A., Lai, H. and Campochiaro, PA. (2006) Effects of different types of oxidative stress in RPE. Cells J Cell Physiol, 206, pp. 119-125.
20. Hsieh, TJ, Liu, TZ, Chia, YC, Chern, CL, Lu, FJ, Chuang, MC, Mau, SY, Chen, SH, Syu, YH and Chen, CH. (2004) Protective effect of methyl gallate from Toona sinensis (Meliaceae) against hydrogen peroxide-induced oxidative stress and DNA damage in MDCK cells. Food Chem Toxicol, 42, pp. 843-850.
21. Olivieri, G., Baysang, G., Meier, F., Müller-Spahn, F., Stähelin, HB, Brockhaus, M. and Brack, Ch (2001) N-Acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: Effects on β-amyloid secretion and tau phosphorylation. J Neurochem, 76, pp. 224-233.
22. Smith, JV and Luo, Y. (2003) Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Gingko biloba extract EGb 761. J Alzh Dis, 5, pp. 287-300.
23. McGeer, EG and McGeer, PL. (2003) Inflammatory processes in Alzheimer's disease. Progr Neuro-Physiopharm Biol Psych, 27, pp. 741-749.
24. Manev, H., Sugaya, K. and Qu, T. (2000) Putative role of neuronal 5-Lipoxygenase in an aging brain. FASEB J, 14, pp. 1464-1469.
25. Klegeris, A. and McGeer, PL. (2002) Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging, 23, pp. 787-794.
26. Hoozemans, JJ, Bruckner, MK, Rozemuller, AJ, Veerhuis, R., Eikelenboom, P. and Arendt, T. (2002) Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol, 61, p. 678.
27. Pieroni, C., Winger, D., Purohit, DP, Aisen, PS and Pasinetti, GM. (1999) Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J Neurosci Res, 57, pp. 295-303.
28. Casolini, P., Catalani, A., Zuena, AR and Angelucci, L. (2002) Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res, 68, pp. 337-343.
29. Joseph, JA, Shukitt-Halem, B., Casadesus, G. and Fisher, D. (2005) Oxidative stress and inflammation in brain aging: Nutritional considerations. Neurochem Res, 30, pp. 927-935.
30. Hull, M., Fiebich, BL, Schumann, G., Lieb, K. and Bauer, J. (1999) Anti-inflammatory substances-a new therapeutic option in Alzheimer's disease. Drug Discov Today, 4, pp. 275-282.
31. Weggen, S., Eriksen, JL, Das, P., Sagi, SA, Wang, R., Pietrzik, CU, Findlay, KA, Smith, TE, Murphy, MP, Bulter, T., Kang, DE, Marquez-Sterling, N., Golde, TE and Koo, EH. (2001) A subset of NSAIDs lowers amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature, 414, pp. 212-216.
32. Aisen, PS, Davis, KL, Berg, JD, Schafer, K., Campbell, K., Thomas, RG, Weiner, MF, Farlow, MR, Sano, M., Grundman, M. and Thal, LJ. (2000) A randomised controlled trial of prednisone in Alzheimer's disease. Neurology, 54, pp. 588-593.
33. Wallace, JL, Pittman, QJ and Cirino, G. (1995) Nitric-oxide-releasing NSAIDs: A novel class of GI-sparing anti-inflammatory drugs, agents. Actions Suppl, 46, pp. 121-129.
34. Egan, D., O'Kennedy, E., Moran, E., Cox, D., Prosser, E. and Thornes, RD. (1990) The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev, 22, pp. 503-529.
35. Murray, RDH, Mendez, I. and Brawn, SA. (1982) The natural coumarins, Wiley, New York
36. Neichi, T., Koshihara, Y. and Mutora, SI. (1983) Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim Biophys Acta, 753, pp. 130-132.
37. Kimura, Y., Okuda, H., Arichi, S., Baba, K. and Kozawa, M. (1985) Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Biochim Biophys Acta, 834, pp. 224-229.
38. Craven, PA, Pfanstiel, J. and De Rubertis, FR. (1986) Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation. J Clin Invest, 77, pp. 850-859.
39. Ozaki, Y., Ohashi, T. and Niwa, Y. (1986) A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. Biochem Pharmacol, 35, pp. 3481-3488.
40. Paya, M., Halliwell, B. and Hoult, JRS. (1992) Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol, 44, pp. 205-214.
41. Mora, A., Paya, M., Rios, JL and Alcaraz, MJ. (1990) Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem Pharmacol, 40, pp. 793-797.
42. Kang, SY, Lee, KY, Park, MJ and Kim, YC. (2001) Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: Structure-activity relationships. J Nat Prod, 64, pp. 683-685.
43. Yan, JJ, Kim, DH, Moon, YS, Jung, JS, Ahn, EM, Baek, NI and Song, DK. (2004) Protection against β-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigaw or decursinol in mice. Progr Neuro-Psychopharmacol Biol Psych, 28, pp. 25-30.
44. Proteggente, AR, Pannala, AS, Paganga, G., Van Buren, L., Wagner, E., Wiseman, S., Dacombe, C. and Rice-Evans, CA. (2002) The antioxidant acitivity of regularly consumed fruit and vegetables reflects their phenolic and vitamin C composition. Free Radic Res, 36, pp. 217-233.
45. Kaneko, T., Baba, N. and Matsuo, M. (2003) Protection of coumarins against linoleic acid hydroperoxide-induced cytotoxicity. Chem Biol Interact, 142, pp. 239-254.
46. Kontogiorgis, CA and Hadjipavlou-Litina, DJ. (2004) Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett, 14, pp. 611-614.
47. Kontogiorgis, CA and Hadjipavlou-Litina, DJ. (2004) Synthesis and anti-inflammatory activity of coumarin derivatives. J Med Chem, 48, pp. 6400-6408.
48. Kontogiorgis, CA and Hadjipavlou-Litina, DJ. (2006) Antiinflammatory abd antioxidant evaluation of novel coumarin derivatives. J Enz Inhib Med Chem, 21, pp. 21-29.
49. Thinakaran, G., Teplow, DB, Siman, R., Greengard, P. and Sisodia, SS. (1996) Metabolism of the 'Swedish' amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the 'beta-secretase' site occurs in the golgi apparatus. J Biol Chem, 271, pp. 9390-9397.
50. Cai, D., Leem, JY, Greenfield, JP, Wang, P., Kim, BS, Wang, R., Lopes, KO, Kim, SH, Zheng, H., Greengard, P., Sisodia, SS, Thianakan, G. and Xu, H. (2003) Presenilin-1 regulates intecelular trafficking and cell surface delivery of beta-amyloid precursor protein. J Biol Chem, 278, pp. 3446-3454.
51. Parent, AT, Barnes, NY, Taniguchi, Y., Thinakaran, G. and Sisodia, SS. (2005) Presenilin attenuates receptor-mediated signalling and synaptic function. J Neurosci, 25, pp. 1540-1549.
52. Luo, Y., Smith, JV, Paramasivam, V., Burdick, A., Curry, KJ, Buford, JP, Khan, I., Netzer, WJ and Butko, P. (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Gingko biloba extract EGb761. Proc Natl Acad Sci USA, 99, pp. 12197-12202.
53. Thinakaran, G., Bowen, JW, Ito, D., Leem, JY, Veselits, ML and Sato, N. (2003) Investigation of unfolded-protein response in cells expressing familial Alzheimer's disease-linked presenilin variants. Methods Mol Biol, 232, pp. 203-216.
54. Sweeney, D., Wang, R., Thinakaran, G., Lo, AC, Sisodia, SS, Greengard, P. and Gandy, S. (1997) Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc Natl Acad Sci USA, 94, pp. 3748-3752.
55. 2 in cultured endothelial cells. Arch Biochem Biophys, 302, pp. 348-355.
56. Gniadecki, R., Christoffersen, N. and Wulf, HC. (2002) Cholesterol-rich plasma membrane domains (lipid rafts) in keratinocytes: Importance in the baseline and UVA-induced generation of reactive oxygen species. J Invest Dermatol, 118, pp. 582-588.
57. Marchesi, E., Rota, C., Fann, YC, Chignell, CF and Mason, RP. (1999) Photoreduction of the fluorescent dye 2′,7′-dichlorofluorescein: A spin trapping and direct electron spin resonance study with implications for oxidative stress measurements. Free Radic Biol Med, 26, pp. 148-161.
58. Chignell, CF and Sik, RH. (2003) A photochemical study of cells loaded with 2′,7′-dichlorodluorescin: Implications for the detection of reactive oxygen species generated during UVA irradiation. Free Rad Biol Med, 34, pp. 1029-1034.
59. Slater, TF, Sawyer, B. and Straeuli, U. (1963) Studies on succinate-tetrazolium peductase systems. III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta, 77, pp. 383-393.
60. Yatin, SM, Varadarajan, S., Link, CD and Butterfield, DA. (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42). Neurobiol Aging, 20, pp. 325-330.
61. Whang, WK, Park, HS, Ham, I., Namkoong, H., Kim, HK, Hwang, DW, Hur, SY, Kim, TE, Park, YG, Kim, JR and Kim, JW. (2005) Natural compounds, fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Exp Mel Med, 37, pp. 436-446.
62. Molina-Jimenez, MF, Sanchez-Reus, MI and Benedi, J. (2003) Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH-SY5Y cells: Comparison with N-acetylcysteine. Eur J Pharmacol, 472, pp. 81-87.
63. Elinos-Baez, CM, Leon, F. and Santos, E. (2005) Effects of coumarin and 7OH-coumarin on bcl-2 and bax expression in two human lung cancer cell lines in vitro. Cell Biol Int, 29, pp. 703-708.